These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31326500)

  • 1. Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer.
    Joshi SS; Handorf ER; Sienko D; Zibelman M; Uzzo RG; Kutikov A; Horwitz EM; Smaldone MC; Geynisman DM
    Eur Urol Oncol; 2020 Feb; 3(1):104-111. PubMed ID: 31326500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis.
    Joshi SS; Handorf EA; Zibelman M; Plimack ER; Uzzo RG; Kutikov A; Smaldone MC; Geynisman DM
    Eur Urol; 2018 Sep; 74(3):387-393. PubMed ID: 29880274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy.
    Sebastian N; Goyal S; Liu Y; Janopaul-Naylor JR; Patel PR; Dhere VR; Hanasoge S; Shelton JW; Godette KD; Jani AB; Hershatter B; Fischer-Valuck B; Patel SA
    JAMA Netw Open; 2023 Aug; 6(8):e2327637. PubMed ID: 37552479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
    Chen YW; Mahal BA; Muralidhar V; Nezolosky M; Beard CJ; Den RB; Feng FY; Hoffman KE; Martin NE; Orio PF; Nguyen PL
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):683-90. PubMed ID: 26972640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facility Volume and Survival in Nasopharyngeal Carcinoma.
    Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Lee NY; Ho AS; Zumsteg ZS
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):408-417. PubMed ID: 29100787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.
    Barzi A; Lara PN; Tsao-Wei D; Yang D; Gill IS; Daneshmand S; Klein EA; Pinski JK; Penson DF; Quinn DI; Sadeghi S
    Cancer; 2019 Nov; 125(21):3853-3863. PubMed ID: 31398279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.
    Yang DD; Mahal BA; Muralidhar V; Martin NE; Orio PF; Mouw KW; King MT; Choueiri TK; Trinh QD; Hoffman KE; Spratt DE; Feng FY; Nguyen PL
    Eur Urol; 2019 Jan; 75(1):35-41. PubMed ID: 30554605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphoma.
    Go RS; Al-Hamadani M; Shah ND; Crowson CS; Holton SJ; Habermann EB
    Cancer; 2016 Aug; 122(16):2552-9. PubMed ID: 27182831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachytherapy Boost Utilization and Survival in Unfavorable-risk Prostate Cancer.
    Johnson SB; Lester-Coll NH; Kelly JR; Kann BH; Yu JB; Nath SK
    Eur Urol; 2017 Nov; 72(5):738-744. PubMed ID: 28688613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Treatment Facility Volume and Mortality of Patients With Multiple Myeloma.
    Go RS; Bartley AC; Crowson CS; Shah ND; Habermann EB; Holton SJ; Holmes DR
    J Clin Oncol; 2017 Feb; 35(6):598-604. PubMed ID: 28199819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer.
    Goyal G; Kommalapati A; Bartley AC; Gunderson TM; Adjei AA; Go RS
    Lung Cancer; 2018 Aug; 122():214-219. PubMed ID: 30032834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
    Rusthoven CG; Jones BL; Flaig TW; Crawford ED; Koshy M; Sher DJ; Mahmood U; Chen RC; Chapin BF; Kavanagh BD; Pugh TJ
    J Clin Oncol; 2016 Aug; 34(24):2835-42. PubMed ID: 27325855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of primary nonmetastatic melanoma at high-volume academic facilities is associated with improved long-term patient survival.
    Cheraghlou S; Agogo GO; Girardi M
    J Am Acad Dermatol; 2019 Apr; 80(4):979-989. PubMed ID: 30365997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facility Volume as a Prognosticator of Survival in Locally Advanced Papillary Thyroid Cancer.
    Abiri A; Pang JC; Roman K; Goshtasbi K; Birkenbeuel JL; Kuan EC; Tjoa T; Haidar YM
    Laryngoscope; 2023 Feb; 133(2):443-450. PubMed ID: 35822421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual Facility Treatment Volume and Patient Survival for Mycosis Fungoides and Sézary Syndrome.
    Kann BH; Park HS; Yeboa DN; Aneja S; Girardi M; Foss FM; Roberts KB; Wilson LD
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):520-526.e2. PubMed ID: 28655598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
    Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
    Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
    Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.